DuPont de Nemours Valuation: Undervalued by 42% or Overvalued by 32%?

DuPont de Nemours is estimated to be 42% undervalued based on its current share price of $76.92 and a projected fair value of $132 using a 2-stage free cash flow to equity model. The analyst price target for DD is $89.31, which is 32% below the estimated fair value.

DuPont de Nemours, Inc. (NYSE: DD) is currently trading at $76.92 per share, with analysts estimating that the stock is 42% undervalued based on a projected fair value of $132. This valuation is derived from a 2-stage free cash flow to equity model, indicating that the company's current market price may not fully reflect its intrinsic value [1].

The analyst price target for DuPont de Nemours is $89.31, which is 32% below the estimated fair value. This discrepancy suggests that investors may be missing out on potential upside, given the current market conditions and the company's fundamentals. However, it is essential to consider other factors such as market sentiment and macroeconomic conditions when evaluating investment opportunities.

In addition to the valuation metrics, it is crucial to assess DuPont de Nemours' recent performance and financial health. The company reported a quarterly earnings per share (EPS) of $1.12, exceeding analyst expectations of $1.06 and reflecting a year-over-year revenue increase of 2.7% to $3.26 billion [2]. This positive performance indicates that the company is on track to meet its financial goals and may be well-positioned for future growth.

Investors should also consider the company's valuation relative to its peers and industry averages. DuPont de Nemours' price-to-sales (PS) ratio of 2.6x is slightly above the peer average of 2.6x, suggesting that the company may be relatively expensive compared to its competitors. However, it is essential to evaluate these metrics in the context of the company's specific business model and growth prospects.

In conclusion, DuPont de Nemours appears to be undervalued based on current analyst estimates and valuation models. However, investors should conduct thorough due diligence and consider other factors such as recent performance, peer comparisons, and market sentiment before making investment decisions.

References:
[1] https://simplywall.st/stocks/us/materials/nyse-dd/dupont-de-nemours/valuation
[2] https://www.marketbeat.com/instant-alerts/filing-allstate-corp-trims-holdings-in-dupont-de-nemours-inc-dd-2025-08-26/